Trial intelligence / Profile preview

Neoadjuvant capecitabine + oxaliplatin with PD-1 inhibitor and immunonutrition versus chemotherapy alone for locally advanced gastric or gastroesophageal junction adenocarcinoma

ChiCTR2300077461Phase 2Recruiting

Sponsor

Sichuan Cancer Hospital

Start

Nov 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1